We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Genetic Studies Reveal New Causes of Severe Obesity in Childhood

Research funded by the Wellcome Trust has discovered that the loss of a key segment of DNA can lead to severe childhood obesity.
News

Potential New 'Twist' in Breast Cancer Detection

Mouse studies reveal new and better picture of stem cells that may fuel some breast cancers.
News

Scientists’ Genetic Mapping of Han Chinese Provides Invaluable Information of Ethnic Chinese Ancestry

Findings provides invaluable information to determine the design and interpretation of genetic studies of human diseases.
News

SickKids Scientists Scratch Below the Surface and Identify a Stem Cell for the Lower Layer of the Skin

Study finds skin-derived precursors which can maintain the dermis and participate in wound healing.
News

VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops

Findings published in the journal Nature could help engineer hardier plants and have implications for stress disorders in humans.
News

Fluxion Expands Into Asia With First China Sale, Distributors in Korea and Japan

Fluxion Biosciences announced today that it has expanded its sales and service network into Asia. The company signed a distribution agreement for its BioFlux™ line with Korea-based DI Biotech.
News

DNA Electronics Wins R&D Prize At Elektra09 European Electronics Industry Awards

Imperial College London Spin-out DNA Electronics Wins For “SNP Dr” Real-Time Gene Testing Innovation
News

BNC Heads for a Hat Trick

A triplet of awards in the offing for the specialist bio-nanotechnology product development consultancy
News

The Magnitude and Impacts of the Biotech and Organic Seed Price Premium: US Organic Center report assessment

The mainstream US market evidence does not support the Organic Center report conclusions.
News

Alkermes Licenses Technology Platform for Long-Acting Fusion Proteins from Acceleron Pharma

The licensed Medifusion™ technology to be used to develop a long-acting TNF inhibitor for the treatment of rheumatoid arthritis.
Advertisement